Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Guelph
$105,000.00
Evaluation of the human burden of disease from third generation cephalosporin resistant Escherichia coli and Salmonella infections and the contribution from antimicrobial use in food producing animals
FY 2016-17
Summary
Antibiotics are used to treat bacterial infections that can be serious and in some cases fatal. They have saved countless lives and have extended life expectancy since their discovery in the early 20th century. Unfortunately, their widespread use also contributes to the development and spread of antibiotic resistance in illness-causing bacteria, with the result that antibiotic treatment becomes ineffective. The problem is a serious 21st century global public health crisis and steps need to be taken urgently to preserve the effectiveness of these precious medicines. Many types of antibiotics are used both in humans and animals. While it is known that antibiotic use in food animals can lead to antibiotic resistance, the extent to which this use contributes to resistant bacterial infections in humans is unknown. This research will address this important need by determining the impact of antibiotic resistance in enteric (gut-related) bacteria on human health in Canada and the contribution from antibiotic use in animals, focusing on 3rd generation cephalosporin resistance in Escherichia coli (E. coli) and Salmonella. There are three components to the research: 1) determination of the human health impact of antibiotic resistance in selected E. coli and Salmonella human infections; 2) identification of the proportion of these antibiotic resistant infections involving animal sources; and 3) mathematical modelling of antibiotic resistance selection by antibiotic use in animals, spread of resistant E. coli and Salmonella through contaminated food and environment to humans, and resultant risk of human illness from antibiotic resistant infection with these bacteria. The results from this research are essential for improvement of veterinary antibiotic use policy in Canada and around the globe. All Canadians will benefit from improved and appropriate antibiotic use that will preserve current antibiotic effectiveness and reduce the rate of development of antibiotic resistance.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
365485
Name
MacKinnon Melissa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - A
Projecttitle
Evaluation of the human burden of disease from third generation cephalosporin resistant Escherichia coli and Salmonella infections and the contribution from antimicrobial use in food producing animals
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Antibiotic; Antimicrobial; Antimicrobial Resistance; Burden Of Disease; Epidemiology; Escherichia Coli; Food Safety; Public Health; Salmonella; Surveillance
Abstract
Antibiotics are used to treat bacterial infections that can be serious and in some cases fatal. They have saved countless lives and have extended life expectancy since their discovery in the early 20th century. Unfortunately, their widespread use also contributes to the development and spread of antibiotic resistance in illness-causing bacteria, with the result that antibiotic treatment becomes ineffective. The problem is a serious 21st century global public health crisis and steps need to be taken urgently to preserve the effectiveness of these precious medicines. Many types of antibiotics are used both in humans and animals. While it is known that antibiotic use in food animals can lead to antibiotic resistance, the extent to which this use contributes to resistant bacterial infections in humans is unknown. This research will address this important need by determining the impact of antibiotic resistance in enteric (gut-related) bacteria on human health in Canada and the contribution from antibiotic use in animals, focusing on 3rd generation cephalosporin resistance in Escherichia coli (E. coli) and Salmonella. There are three components to the research: 1) determination of the human health impact of antibiotic resistance in selected E. coli and Salmonella human infections; 2) identification of the proportion of these antibiotic resistant infections involving animal sources; and 3) mathematical modelling of antibiotic resistance selection by antibiotic use in animals, spread of resistant E. coli and Salmonella through contaminated food and environment to humans, and resultant risk of human illness from antibiotic resistant infection with these bacteria. The results from this research are essential for improvement of veterinary antibiotic use policy in Canada and around the globe. All Canadians will benefit from improved and appropriate antibiotic use that will preserve current antibiotic effectiveness and reduce the rate of development of antibiotic resistance.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
MacKinnon, Melissa
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~